Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Thalidomide × 30 days × Clear all

Phase

Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Recurrence 1 Medulloblastoma 1 Ependymoma 1

Interventions

Specimen Handling 146 Magnetic Resonance Spectroscopy 122 Biopsy 91 pembrolizumab 88 Cyclophosphamide 68 Carboplatin 68 Paclitaxel 57 Cisplatin 57 Nivolumab 45 venetoclax 43 Radiotherapy 39 durvalumab 35 Gemcitabine 35 fludarabine 34 olaparib 33 Dexamethasone 33 Radiation 32 Rituximab 30 Bevacizumab 30 atezolizumab 29 Oxaliplatin 29 X-Rays 28 Prednisone 28 Fluorouracil 27 Docetaxel 27 Cytarabine 26 Lenalidomide 25 Ipilimumab 25 Etoposide 25 Azacitidine 24

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01356290 2026-02-23

MEMMAT

Medical University of Vienna

Phase 2 Recruiting

Ependymoma, Medulloblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡